Injectable hydrogels for central nervous system therapy

Biomedical Materials

Volumn 7, Issue 2, 2012, Pages

  Pakulska, Malgosia M ^a,b   Ballios, Brian G ^c   Shoichet, Molly S ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLIC MONOMERS; CYTOLOGY; DISEASE CONTROL; DRUG DELIVERY; MOLECULES; STEM CELLS; TISSUE;

ADHESIVE MATRICES; BIORESORBABLE HYDROGELS; BLOOD-BRAIN BARRIER; CELL AGGREGATION; CELL DELIVERY; CELL SURVIVAL; CELL TRANSPLANTS; CELLULAR DEGENERATION; CELLULAR GROWTH; CENTRAL NERVOUS SYSTEMS; FUNCTIONAL RECOVERY; HYALURONAN; INJECTABLE HYDROGELS; METHYLCELLULOSE; MINIMALLY INVASIVE; N-ISOPROPYLACRYLAMIDES; NEUROPROTECTIVE AGENTS; NEUROTROPHIC FACTORS; PROMISING THERAPY; PROTEIN DRUGS; REGENERATIVE CAPACITY; SMALL MOLECULES; SPINAL CORDS; SUSTAINED RELEASE; THERAPEUTIC USE;

HYDROGELS;

AGAROSE; ALGINIC ACID; BIOMATERIAL; BRAIN DERIVED NEUROTROPHIC FACTOR; CHITOSAN; CILIARY NEUROTROPHIC FACTOR; COLLAGEN IMPLANT; COPOLYMER; EPIDERMAL GROWTH FACTOR; FIBRIN; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; GROWTH FACTOR; HYALURONIC ACID; MATRIGEL; METHYLCELLULOSE; N ACETYLGALACTOSAMINE 4 SULFATASE; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NIMODIPINE; POLOXAMER; POLY(N ISOPROPYLACRYLAMIDE); POLYACRYLONITRILE; POLYGLACTIN; POLYLACTIC ACID; POLYMACON; POLYMER; POLYPROPYLENE; POLYURETHAN; POLYVINYLCHLORIDE; DRUG CARRIER;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN DISEASE; CELL ENCAPSULATION; CELL THERAPY; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM DISEASE; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; DRUG IMPLANT; HISTOLOGY; HUMAN; HYDROGEL; NONHUMAN; PARKINSON DISEASE; RETINA DISEASE; REVIEW; SPINAL CORD DISEASE; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; STROKE; SUSTAINED DRUG RELEASE; TREATMENT OUTCOME; ANIMAL; DRUG EFFECT; INJECTION; NERVE REGENERATION; TISSUE ENGINEERING; TISSUE REGENERATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; CENTRAL NERVOUS SYSTEM DISEASES; DRUG CARRIERS; GUIDED TISSUE REGENERATION; HUMANS; HYDROGELS; INJECTIONS; NERVE REGENERATION; TISSUE ENGINEERING;

EID: 84859413635     PISSN: 17486041     EISSN: 1748605X     Source Type: Journal    
DOI: 10.1088/1748-6041/7/2/024101     Document Type: Review

References (168)

1. Jacobs W B and Fehlings M G 2003 The molecular basis of neural regeneration Neurosurgery 53 943-50
2. Mason C and Dunnill P 2007 A brief definition of regenerative medicine Regen. Med. 3 1-5 (Pubitemid 351541190)
3. Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, Marshall V and Jones J 1998 Embryonic stem cell lines derived from human blastocysts Science 282 1145-7 (Pubitemid 28516247)
4. Morshead C M, Reynolds B A, Craig C G, McBurney M W, Staines W A, Morassutti D, Weiss S and Van der Kooy D 1994 Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells Neuron 13 1071-82 (Pubitemid 24372126)
5. Chiasson B J, Tropepe V, Morshead C M and Van der Kooy D 1999 Adult mammalian forebrain ependymal and subependymal cells demonstrate proliferative potential, but only subependymal cells have neural stem cell characteristics J. Neurosci. 19 4462-71 (Pubitemid 29241097)
6. Thuret S, Moon L D F and Gage F H 2006 Therapeutic interventions after spinal cord injury Nat. Rev. Neurosci. 7 628-43 (Pubitemid 44106745)
7. Buchli A D and Schwab M E 2005 Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system Ann. Med. 37 556-67 (Pubitemid 41780144)
8. Steward O, Sharp K, Yee K M and Hofstadter M 2008 A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice Exp. Neurol. 209 446-68
9. Bradbury E J, Moon L D F, Popat R J, King V R, Bennett G S, Patel P N, Fawcett J W and McMahon S B 2002 Chondroitinase ABC promotes functional recovery after spinal cord injury Nature 416 636-40 (Pubitemid 34406764)
10. Hyatt A J T, Wang D, Kwok J C, Fawcett J W and Martin K R 2010 Controlled release of chondroitinase ABC from fibrin gel reduces the level of inhibitory glycosaminoglycan chains in lesioned spinal cord J. Control. Release 147 24-9
11. Mitterreiter S et al 2010 Bepridil and amiodarone simultaneously target the Alzheimer's disease β- and γ -secretase via distinct mechanisms J. Neurosci. 30 8974-83
12. Outeiro T F et al 2007 Sirtuin 2 inhibitors rescue α-synuclein- mediated toxicity in models of Parkinson's disease Science 317 516-9 (Pubitemid 47196116)
13. Hurlbert R J and Hamilton M G 2008 Methylprednisolone for acute spinal cord injury: 5-year practice reversal Can. J. Neurol. Sci. 35 41-5 (Pubitemid 351518287)
14. Dessy A and Gorman J M 2011 The emerging therapeutic role of RNA interference in disorders of the central nervous system Clin. Pharmacol. Ther. 89 450-4
15. Ding H L, Schwarz D S, Keene A, Affar E B, Fenton L, Xia X A, Shi Y, Zamore P D and Xu Z S 2003 Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis Aging Cell 2 209-17
16. Al-Jamal K T et al 2011 Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing Proc. Natl Acad. Sci. USA 108 10952-7
17. Zhao R R et al 2011 Lentiviral vectors express chondroitinase ABC in cortical projections and promote sprouting of injured corticospinal axons J. Neurosci. Methods 201 228-38
18. Eberling J L, Jagust W J, Christine C W, Starr P, Larson P, Bankiewicz K S and Aminoff M J 2008 Results from a phase I safety trial of hAADC gene therapy for Parkinson disease Neurology 70 1980-3
19. Rubin L L and Staddon J M 1999 The cell biology of the blood brain barrier Annu. Rev. Neurosci. 22 11-28 (Pubitemid 29144879)
20. Gaillard P J, Visser C C and de Boer A G 2005 Targeted delivery across the blood-brain barrier Expert Opin. Drug Deliv. 2 299-309 (Pubitemid 41130884)
21. Pardridge W M 1997 Drug delivery to the brain J. Cereb. Blood Flow Metab. 17 713-31 (Pubitemid 27427575)
22. Lavik E, Kuehn M H and Kwon Y H 2011 Novel drug delivery systems for glaucoma Eye 25 578-86
23. de Boer A G and Gaillard P J 2007 Drug targeting to the brain Annu. Rev. Pharmacol. Toxicol. 47 323-55
24. Jablonska B, Gierdalska M, Kublik A, Skangiel-Kramska J and Kossut M 1993 Effects of implantation of Alzet 1007D osmotic minipumps upon 2-deoxyglucose uptake in the cerebral cortex of mice Acta Neurobiol. Exp. (Wars.) 53 577-80 (Pubitemid 24062154)
25. Follett K A, Boortz-Marx R L, Drake J M, DuPen S, Schneider S J, Turner M S and Coffey R J 2004 Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections Anesthesiology 100 1582-94 (Pubitemid 38679330)
26. Penn R D, York M M and Paice J A 1995 Catheter systems for intrathecal drug delivery J. Neurosurg. 83 215-7
27. Jain R K 1990 Tumor physiology and antibody delivery Front. Radiat. Ther. Oncol. 24 32-46 discussion 64-8
28. Patane M A, Cohen A E, Sheppard J D and Nguyen Q D 2011 Ocular iontophoresis for drug delivery Retina Today (Bryn Mawr Communications)
29. Brem H and Langer R 1996 Polymer-based drug delivery to the brain Sci. Med. 3 52
30. Ulery B D, Nair L S and Laurencin C T 2011 Biomedical applications of biodegradable polymers J. Polym. Sci. B 49 832-64
31. Peppas N A, Hilt J Z, Khademhosseini A and Langer R 2006 Hydrogels in biology and medicine: from molecular principles to bionanotechnology Adv. Mater. 18 1345-60 (Pubitemid 43898575)
32. Weber L M, Lopez C G and Anseth K S 2009 Effects of PEG hydrogel crosslinking density on protein diffusion and encapsulated islet survival and function J. Biomed. Mater. Res. A 90 720-9
33. Nuttelman C R, Tripodi M C and Anseth K S 2006 Dexamethasone- functionalized gels induce osteogenic differentiation of encapsulated hMSCs J. Biomed. Mater. Res. A 76 183-95 (Pubitemid 43075696)
34. Schoenmakers R G, van de Wetering P, Elbert D L and Hubbell J A 2004 The effect of the linker on the hydrolysis rate of drug-linked ester bonds J. Control. Release 95 291-300 (Pubitemid 38230043)
35. Maherani B, Arab-Tehrany E, Mozafari M R, Gaiani C and Linder M 2011 Liposomes: a review of manufacturing techniques and targeting strategies Curr. Nanosci. 7 436-52
36. Lee H, McKeon R J and Bellamkonda R V 2010 Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury Proc. Natl Acad. Sci. USA 107 3340-5
37. Oh J K, Drumright R, Siegwart D J and Matyjaszewski K 2008 The development of microgels/nanogels for drug delivery applications Prog. Polym. Sci. 33 448-77
38. Edlund U and Albertsson A C 2002 Degradable polymer microspheres for controlled drug delivery Adv. Polym. Sci. 157 67-112
39. Lampe K J, Kern D S, Mahoney M J and Bjugstad K B 2011 The administration of BDNF and GDNF to the brain via PLGA microparticles patterned within a degradable PEG-based hydrogel: protein distribution and the glial response J. Biomed. Mater. Res. A 96 595-607
40. Baumann M D, Kang C E, Tator C H and Shoichet M S 2010 Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury Biomaterials 31 7631-9
41. Hoare T R and Kohane D S 2008 Hydrogels in drug delivery: progress and challenges Polymer 49 1993-2007
42. Van Tomme S R, Storm G and Hennink W E 2008 In situ gelling hydrogels for pharmaceutical and biomedical applications Int. J. Pharm. 355 1-18
43. Sawhney A S, Pathak C P and Hubbell J A 1993 Bioerodible hydrogels based on photopolymerized poly(ethylene glycol)-co-poly(α-hydroxy acid) diacrylate macromers Macromolecules 26 581-7
44. Johl S S and Burgett R A 2006 Dermal filler agents: a practical review Curr. Opin. Ophthalmol. 17 471-9 (Pubitemid 44319040)
45. Lapcík L, De Smedt S, Demeester J and Chabrecek P 1998 Hyaluronan: preparation, structure, properties, and applications Chem. Rev. 98 2663-84
46. Jain A, Kim Y-T, McKeon R J and Bellamkonda R V 2006 In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury Biomaterials 27 497-504 (Pubitemid 41457252)
47. Aymard P, Martin D R, Plucknett K, Foster T J, Clark A H and Norton I T 2001 Influence of thermal history on the structural and mechanical properties of agarose gels Biopolymers 59 131-44 (Pubitemid 32694751)
48. Kim Y T, Caldwell J M and Bellamkonda R V 2009 Nanoparticle-mediated local delivery of methylprednisolone after spinal cord injury Biomaterials 30 2582-90
49. Kwon B K, Mann C, Sohn H M, Hilibrand A S, Phillips F M, Wang J C and Fehlings M G 2008 Hypothermia for spinal cord injury Spine J. 8 859-74
50. Martin B C, Minner E J, Wiseman S L, Klank R L and Gilbert R J 2008 Agarose and methylcellulose hydrogel blends for nerve regeneration applications J. Neural Eng. 5 221-31 (Pubitemid 351999189)
51. Monteiro O A C Jr and Airoldi C 1999 Some studies of crosslinking chitosan-glutaraldehyde interaction in a homogeneous system Int. J. Biol. Macromol. 26 119-28 (Pubitemid 29428241)
52. Calvo P, Remunan-Lopez C, Vila-Jato J L and Alonso M J 1997 Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers J. Appl. Polym. Sci. 63 125-32 (Pubitemid 127613982)
53. Kim S, Nishimoto S K, Bumgardner J D, Haggard W O, Gaber M W and Yang Y Z 2010 A chitosan/beta-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer Biomaterials 31 4157-66
54. Sakiyama-Elbert S E and Hubbell J A 2000 Development of fibrin derivatives for controlled release of heparin-binding growth factors J. Control. Release 65 389-402 (Pubitemid 30122941)
55. Oju J, Soo Hyun R, Ji Hyung C and Kim B-S 2005 Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin J. Control. Release 105 249-59 (Pubitemid 40941990)
56. Sakiyama-Elbert S E and Hubbell J A 2000 Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix J. Control. Release 69 149-58
57. Johnson P J, Parker S R and Sakiyama-Elbert S E 2010 Fibrin-based tissue engineering scaffolds enhance neural fiber sprouting and delay the accumulation of reactive astrocytes at the lesion in a subacute model of spinal cord injury J. Biomed. Mater. Res. A 92 152-63
58. King V, Alovskaya A, Wei D, Brown R and Priestley J 2010 The use of injectable forms of fibrin and fibronectin to support axonal ingrowth after spinal cord injury Biomaterials 31 4447-56
59. Johnson P J, Parker S R and Sakiyama-Elbert S E 2009 Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury Biotechnol. Bioeng. 104 1207-14
60. Di Lullo G A, Sweeney S M, Körkkö J, Ala-Kokko L and San Antonio J D 2002 Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen J. Biol. Chem. 277 4223-31 (Pubitemid 34968685)
61. Bai F S, Peng H, Etlinger J D and Zeman R J 2010 Partial functional recovery after complete spinal cord transection by combined chondroitinase and clenbuterol treatment Pflugers Arch. 460 657-66
62. Joosten E A J, Bär P R and Gispen W H 1995 Collagen implants and cortico-spinal axonal growth after mid-thoracic spinal cord lesion in the adult rat J. Neurosci. Res. 41 481-90
63. Macaya D, Ng K K and Spector M 2011 Injectable Collagen-Genipin gel for the treatment of spinal cord injury: in vitro studies Adv. Funct. Mater. 21 4788-97
64. Yang Z, Qiao H and Li X 2010 Effects of the CNTF-collagen gel-controlled delivery system on rat neural stem/progenitor cells behavior Sci. China Life Sci. 53 504-10
65. Wang J, Lee I L, Lim W S, Chia S M, Yu H, Leong K W and Mao H-Q 2004 Evaluation of collagen and methylated collagen as gene carriers Int. J. Pharm. 279 115-26 (Pubitemid 38968647)
66. Yang C Y, Song B B, Ao Y, Nowak A P, Abelowitz R B, Korsak R A, Havton L A, Deming T J and Sofroniew M V 2009 Biocompatibility of amphiphilic diblock copolypeptide hydrogels in the central nervous system Biomaterials 30 2881-98
67. Tysseling-Mattiace V M, Sahni V, Niece K L, Birch D, Czeisler C, Fehlings M G, Stupp S I and Kessler J A 2008 Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury J. Neurosci. 28 3814-23
68. Cigognini D, Satta A, Colleoni B, Silva D, Donegà M, Antonini S and Gelain F 2011 Evaluation of early and late effects into the acute spinal cord injury of an injectable functionalized self-assembling scaffold PLoS One 6 e19782
69. Tysseling V M, Sahni V, Pashuck E T, Birch D, Hebert A, Czeisler C, Stupp S I and Kessler J A 2010 Self-assembling peptide amphiphile promotes plasticity of serotonergic fibers following spinal cord injury J. Neurosci. Res. 88 3161-70
70. Sahoo S, Chung C, Khetan S and Burdick J A 2008 Hydrolytically degradable hyaluronic acid hydrogels with controlled temporal structures Biomacromolecules 9 1088-92 (Pubitemid 351639559)
71. Zheng S X, Liu Y, Palumbo F S, Luo Y and Prestwich G D 2004 In situ crosslinkable hyaluronan hydrogels for tissue engineering Biomaterials 25 1339-48 (Pubitemid 37476210)
72. Nimmo C M, Owen S C and Shoichet M S 2011 Diels-Alder click cross-linked hyaluronic acid hydrogels for tissue engineering Biomacromolecules 12 824-30
73. Kang C E, Poon P C, Tator C H and Shoichet M S 2009 A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair Tissue Eng. A 15 595-604
74. Gupta D, Tator C H and Shoichet M S 2006 Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord Biomaterials 27 2370
75. Cooke M J, Wang Y, Morshead C M and Shoichet M S 2011 Controlled epi-cortical delivery of epidermal growth factor for the stimulation of endogenous neural stem cell proliferation in stroke-injured brain Biomaterials 32 5688-97
76. Kang C E, Tator C H and Shoichet M S 2010 Poly(ethylene glycol) modification enhances penetration of fibroblast growth factor 2 to injured spinal cord tissue from an intrathecal delivery system J. Control. Rel. 144 25-31
77. Baumann M D, Kang C E, Stanwick J C, Wang Y, Kim H, Lapitsky Y and Shoichet M S 2009 An injectable drug delivery platform for sustained combination therapy J. Control. Rel. 138 205-13
78. Wang Y F, Lapitsky Y, Kang C E and Shoichet M S 2009 Accelerated release of a sparingly soluble drug from an injectable hyaluronan-methylcellulose hydrogel J. Control. Rel. 140 218-23
79. Tate M C, Shear D A, Hoffman S W, Stein D G and LaPlaca M C 2001 Biocompatibility of methylcellulose-based constructs designed for intracerebral gelation following experimental traumatic brain injury Biomaterials 22 1113-23 (Pubitemid 32229936)
80. Gil E S and Hudson S M 2004 Stimuli-responsive polymers and their bioconjugates Prog. Polym. Sci. 29 1173-222
81. Zhang J and Peppas N A 2000 Synthesis and characterization of pH- and temperature-sensitive poly(methacrylic acid)/poly(N-isopropylacrylamide) interpenetrating polymeric networks Macromolecules 33 102-7 (Pubitemid 32212698)
82. Rzaev Z M O, Dincer S and Piskin E 2007 Functional copolymers of N-isopropylacrylamide for bioengineering applications Prog. Polym. Sci. 32 534-95 (Pubitemid 46670215)
83. Vernengo J, Fussell G W, Smith N G and Lowman A M 2008 Evaluation of novel injectable hydrogels for nucleus pulposus replacement J. Biomed. Mater. Res. B 84 64-9
84. Conova L, Kubinski P, Jin Y, Vernengo J, Neuhuber B, Fischer I, Lowman A and IEEE 2010 Injectable multifunctional scaffold for spinal cord repair 36th Annu. Northeast Bioengineering Conf. (IEEE, New York) p 1-2
85. Comolli N, Neuhuber B, Fischer I and Lowman A 2009 In vitro analysis of PNIPAAm-PEG, a novel, injectable scaffold for spinal cord repair Acta Biomater. 5 1046-55
86. Turturro S B, Guthrie M J, Appel A A, Drapala P W, Brey E M, Perez-Luna V H, Mieler W F and Kang-Mieler J J 2011 The effects of cross-linked thermo-responsive PNIPAAm-based hydrogel injection on retinal function Biomaterials 32 3620-6
87. Piantino J, Burdick J A, Goldberg D, Langer R and Benowitz L I 2006 An injectable, biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and improves performance after spinal cord injury Exp. Neurol. 201 359-67 (Pubitemid 44344229)
88. Strappe P M, Hampton D W, Cachon-Gonzalez B, Fawcett J W and Lever A 2005 Delivery of a lentiviral vector in a Pluronic F127 gel to cells of the central nervous system Eur. J. Pharm. Biopharm. 61 126-33 (Pubitemid 41427620)
89. Geroski D H and Edelhauser H F 2001 Transscleral drug delivery for posterior segment disease Adv. Drug Deliv. Rev. 52 37-48 (Pubitemid 32973637)
90. Lim F and Moss R 1981 Microencapsulation of living cells and tissues J. Pharm. Sci. 70 351-4 (Pubitemid 11068879)
91. Lim F and Sun A 1980 Microencapsulated islets as bioartificial endocrine pancreas Science 210 908-10 (Pubitemid 11169847)
92. Wang L, Shelton R, Cooper P, Lawson M, Triffitt J and Barralet J 2003 Evaluation of sodium alginate for bone marrow cell tissue engineering Biomaterials 24 3475-81 (Pubitemid 36703122)
93. Trivedi N, Keegan M, Steil G, Hollister-Lock J, Hasenkamp W, Colton C, Bonner-Weir S and Weir G 2001 Islets in alginate macrobeads reverse diabetes despite minimal acute insulin secretory responses Transplantation 71 203-11 (Pubitemid 32126100)
94. Feng M and Sefton M 2000 Hydroxyethyl methacrylate-methyl methacrylate (HEMA-MMA) copolymers for cell microencapsulation: effect of HEMA purity J. Biomater. Sci. Polym. Ed. 11 537-45 (Pubitemid 30420962)
95. Dawson R, Broughton R, Stevenson W and Sefton M 1987 Microencapsulation of CHO cells in a hydroxyethyl methacrylate-methyl methacrylate copolymer Biomaterials 8 360-6
96. Winn S, Hammang J, Emerich D, Lee A, Palmiter R and Baetge E 1994 Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons Proc. Natl Acad. Sci. USA 91 2324-8 (Pubitemid 24092096)
97. Kendall A, Hantraye P and Palfi S 2000 Striatal tissue transplantation in non-human primates Prog. Brain Res. 127 381-404 (Pubitemid 35469065)
98. Dunnett S 1990 Is it possible to repair the damaged prefrontal cortex by neural tissue transplantation? Prog. Brain Res. 85 285-96 discussion 296-7
99. Dunnett S and Bjorklund A 1999 Prospects for new restorative and neuroprotective treatments in Parkinson's disease Nature 399 A32-9
100. Emerich D, Winn S, Christenson L, Palmatier M, Gentile F and Sanberg P 1992 A novel approach to neural transplantation in Parkinson's disease: use of polymer-encapsulated cell therapy Neurosci. Biobehav. Rev. 16 437-47
101. Emerich D, Winn S, Harper J, Hammang J, Baetge E and Kordower J 1994 Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons J. Comp. Neurol. 349 148-64 (Pubitemid 24328525)
102. Dulong J and Legallais C 2007 A theoretical study of oxygen transfer including cell necrosis for the design of a bioartificial pancreas Biotechnol. Bioeng. 96 990-8 (Pubitemid 46479561)
103. Hama A and Sagen J 1994 Alleviation of neuropathic pain symptoms by xenogeneic chromaffin cell grafts in the spinal subarachnoid space Brain Res. 651 183-93 (Pubitemid 24222866)
104. Lim G, Zare S, Van Dyke M and Atala A 2010 Cell microencapsulation Adv. Exp. Med. Biol. 670 126-36
105. Santos E, Zarate J, Orive G, Hernandez R and Pedraz J 2010 Biomaterials in cell microencapsulation Adv. Exp. Med. Biol. 670 5-21
106. Millesi H, Zoch G and Reihsner R 1995 Mechanical properties of peripheral nerves Clin. Orthop. Relat. Res. 76-83
107. Dalton P D and Shoichet M S 2001 Creating porous tubes by centrifugal forces for soft tissue application Biomaterials 22 2661-9 (Pubitemid 32727841)
108. Dalton P, Flynn L and Shoichet M 2002 Manufacture of poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) hydrogel tubes for use as nerve guidance channels Biomaterials 23 3843-51 (Pubitemid 34828158)
109. Oudega M, Gautier S E, Chapon P, Fragoso M, Bates M L, Parel J M and Bunge M B 2001 Axonal regeneration into Schwann cell grafts within resorbable poly(alpha-hydroxyacid) guidance channels in the adult rat spinal cord Biomaterials 22 1125-36 (Pubitemid 32229937)
110. Novikov L N, Novikova L N, Mosahebi A, Wiberg M, Terenghi G and Kellerth J O 2002 A novel biodegradable implant for neuronal rescue and regeneration after spinal cord injury Biomaterials 23 3369-76 (Pubitemid 34615643)
111. Zahir T, Nomura H, Guo X D, Kim H, Tator C, Morshead C and Shoichet M 2008 Bioengineering neural stem/progenitor cell-coated tubes for spinal cord injury repair Cell Transplant. 17 245-54 (Pubitemid 351717328)
112. Nomura H, Zahir T, Kim H, Katayama Y, Kulbatski I, Morshead C M, Shoichet M S and Tator C H 2008 Extramedullary chitosan channels promote survival of transplanted neural stem and progenitor cells and create a tissue bridge after complete spinal cord transection Tissue Eng. A 14 649-65
113. Kim H, Tator C H and Shoichet M S 2011 Chitosan implants in the rat spinal cord: biocompatibility and biodegradation J. Biomed. Mater. Res. A 97 395-404
114. Paino C L and Bunge M B 1991 Induction of axon growth into Schwann cell implants grafted into lesioned adult rat spinal cord Exp. Neurol. 114 254-7
115. Montgomery C T and Robson J A 1990 New method of transplanting purified glial cells into the brain J. Neurosci. Methods 32 135-41 (Pubitemid 20173263)
116. Kim H, Zahir T, Tator C and Shoichet M 2011 Effects of dibutyryl cyclic-AMP on survival and neuronal differentiation of neural stem/progenitor cells transplanted into spinal cord injured rats PLoS One 6 e21744
117. Midha R, Shoichet M S, Dalton P D, Cao X, Munro C A, Noble J and Wong M K 2001 Tissue engineered alternatives to nerve transplantation for repair of peripheral nervous system injuries Transplant. Proc. 33 612-5 (Pubitemid 32237539)
118. Bellamkonda R, Ranieri J P and Aebischer P 1995 Laminin oligopeptide derivatized agarose gels allow three-dimensional neurite extension in vitro J. Neurosci. Res. 41 501-9
119. Woerly S, Doan V D, Sosa N, de Vellis J and Espinosa A 2001 Reconstruction of the transected cat spinal cord following NeuroGel implantation: axonal tracing, immunohistochemical and ultrastructural studies Int. J. Dev. Neurosci. 19 63-83 (Pubitemid 32156975)
120. Horn E M, Beaumont M, Shu X Z, Harvey A, Prestwich G D, Horn K M, Gibson A R, Preul M C and Panitch A 2007 Influence of cross-linked hyaluronic acid hydrogels on neurite outgrowth and recovery from spinal cord injury J. Neurosurg. Spine 6 133-40 (Pubitemid 47066056)
121. Hejcl A et al 2008 Acute and delayed implantation of positively charged 2-hydroxyethyl methacrylate scaffolds in spinal cord injury in the rat J. Neurosurg. Spine 8 67-73
122. Klassen H, Sakaguchi D S and Young M J 2004 Stem cells and retinal repair Prog. Retinal Eye Res. 23 149-81 (Pubitemid 38496399)
123. Tomita M, Lavik E, Klassen H, Zahir T, Langer R and Young M J 2005 Biodegradable polymer composite grafts promote the survival and differentiation of retinal progenitor cells Stem Cells 23 1579-88 (Pubitemid 41741007)
124. Tao S, Young C, Redenti S, Zhang Y, Klassen H, Desai T and Young M J 2007 Survival, migration and differentiation of retinal progenitor cells transplanted on micro machined poly(methyl methacrylate) scaffolds to the subretinal space Lab Chip 7 695-701 (Pubitemid 46848695)
125. Neeley W L, Redenti S, Klassen H, Tao S, Desai T, Young M J and Langer R 2008 A microfabricated scaffold for retinal progenitor cell grafting Biomaterials 29 418-26 (Pubitemid 350100796)
126. Redenti S, Neeley W L, Rompani S, Saigal S, Yang J, Klassen H, Langer R and Young M J 2009 Engineering retinal progenitor cell and scrollable poly(glycerol-sebacate) composites for expansion and subretinal transplantation Biomaterials 30 3405-14
127. Sodha S, Wall K, Redenti S, Klassen H, Young M and Tao S 2011 Microfabrication of a three-dimensional polycaprolactone thin-film scaffold for retinal progenitor cell encapsulation J. Biomater. Sci. Polym. Ed. 22 443-56
128. Tucker B A, Redenti S M, Jiang C, Swift J S, Klassen H J, Smith M E, Wnek G E and Young M J 2010 The use of progenitor cell/biodegradable MMP2-PLGA polymer constructs to enhance cellular integration and retinal repopulation Biomaterials 31 9-19
129. Nikkhah G, Cunningham M, Jodicke A, Knappe U and Bjorklund A 1994 Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model Brain Res. 633 133-43 (Pubitemid 24021254)
130. Whittemore S, Zhang Y, Shields C and Magnuson D 2008 Optimizing stem cell grafting into the CNS Methods Mol. Biol. 438 375-82
131. Kubitz J and Motsch J 2003 Eye surgery in the elderly Best Pract. Res. Clin. Anaesthesiol. 17 245-57 (Pubitemid 38937095)
132. Ballios B G, Cooke M J, van der Kooy D and Shoichet M S 2010 A hydrogel-based stem cell delivery system to treat retinal degenerative diseases Biomaterials 31 2555-64
133. Frisch S and Francis H 1994 Disruption of epithelial cell-matrix interactions induces apoptosis J. Cell Biol. 124 619-26 (Pubitemid 24064472)
134. Frisch S and Screaton R 2001 Anoikis mechanisms Curr. Opin. Cell Biol. 13 555-62 (Pubitemid 32817013)
135. Sierpinski P, Garrett J, Ma J, Apel P, Klorig D, Smith T, Koman L, Atala A and Van Dyke M 2008 The use of keratin biomaterials derived from human hair for the promotion of rapid regeneration of peripheral nerves Biomaterials 29 118-28 (Pubitemid 47599650)
136. Flynn L, Dalton P and Shoichet M 2003 Fiber templating of poly(2-hydroxyethyl methacrylate) for neural tissue engineering Biomaterials 24 4265-72 (Pubitemid 36809028)
137. Bozkurt A et al 2007 In vitro assessment of axonal growth using dorsal root ganglia explants in a novel three-dimensional collagen matrix Tissue Eng. 13 2971-9 (Pubitemid 350233084)
138. Wood M and Sakiyama-Elbert S 2008 Release rate controls biological activity of nerve growth factor released from fibrin matrices containing affinity-based delivery systems J. Biomed. Mater. Res. A 84 300-12
139. Yu T and Shoichet M 2005 Guided cell adhesion and outgrowth in peptide-modified channels for neural tissue engineering Biomaterials 26 1507-14 (Pubitemid 39441383)
140. Kallur T, Darsalia V, Lindvall O and Kokaia Z 2006 Human fetal cortical and striatal neural stem cells generate region-specific neurons in vitro and differentiate extensively to neurons after intrastriatal transplantation in neonatal rats J. Neurosci. Res. 84 1630-44 (Pubitemid 44892598)
141. Bakshi A, Keck C, Koshkin V, LeBold D, Siman R, Snyder E and McIntosh T 2005 Caspase-mediated cell death predominates following engraftment of neural progenitor cells into traumatically injured rat brain Brain Res. 1065 8-19 (Pubitemid 41774621)
142. Parr A, Kulbatski I and Tator C 2007 Transplantation of adult rat spinal cord stem/progenitor cells for spinal cord injury J. Neurotrauma 24 835-45 (Pubitemid 46799275)
143. Johann V et al 2007 Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease Exp. Brain Res. 177 458-70 (Pubitemid 46339598)
144. Iihoshi S, Honmou O, Houkin K, Hashi K and Kocsis J 2004 A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats Brain Res. 1007 1-9 (Pubitemid 38520167)
145. Bacigaluppi M et al 2009 Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms Brain 132 2239-51
146. Hill C, Moon L, Wood P and Bunge M 2006 Labeled Schwann cell transplantation: cell loss, host Schwann cell replacement, and strategies to enhance survival Glia 53 338-43 (Pubitemid 43221355)
147. Le Belle J E, Caldwell M A and Svendsen C N 2004 Improving the survival of human CNS precursor-derived neurons after transplantation J. Neurosci. Res. 76 174-83 (Pubitemid 38451205)
148. Takahashi K et al 2008 Embryonic neural stem cells transplanted in middle cerebral artery occlusion model of rats demonstrated potent therapeutic effects, compared to adult neural stem cells Brain Res. 1234 172-82
149. Itosaka H, Kuroda S, Shichinohe H, Yasuda H, Yano S, Kamei S, Kawamura R, Hida K and Iwasaki Y 2009 Fibrin matrix provides a suitable scaffold for bone marrow stromal cells transplanted into injured spinal cord: a novel material for CNS tissue engineering Neuropathology 29 248-57
150. Patel V, Joseph G, Patel A, Patel S, Bustin D, Mawson D, Tuesta L, Puentes R, Ghosh M and Pearse D 2010 Suspension matrices for improved Schwann-cell survival after implantation into the injured rat spinal cord J. Neurotrauma 27 789-801
151. Cooke M J, Vulic K and Shoichet M S 2010 Design of biomaterials to enhance stem cell survival when transplanted into the damaged central nervous system Soft Matter. 6 4988-98
152. Reichert W M 2008 Indwelling neural implants: strategies for contending with the in vivo environment Frontiers in Neuroengineering (Boca Raton, FL: CRC Press)
153. Uemura M, Refaat M, Shinoyama M, Hayashi H, Hashimoto N and Takahashi J 2010 Matrigel supports survival and neuronal differentiation of grafted embryonic stem cell-derived neural precursor cells J. Neurosci. Res. 88 542-51
154. Jin K, Mao X, Xie L, Galvan V, Lai B, Wang Y, Gorostiza O, Wang X and Greenberg D 2010 Transplantation of human neural precursor cells in Matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats J. Cereb. Blood Flow Metab. 30 534-44
155. Lu D, Mahmood A, Qu C, Hong X, Kaplan D and Chopp M 2007 Collagen scaffolds populated with human marrow stromal cells reduce lesion volume and improve functional outcome after traumatic brain injury Neurosurgery 61 596-602 discussion 602-3
156. Tate C C, Shear D A, Tate M C, Archer D R, Stein D G and LaPlaca M C 2009 Laminin and fibronectin scaffolds enhance neural stem cell transplantation into the injured brain J. Tissue Eng. Regen. Med. 3 208-17
157. Tate M C, Shear D A, Hoffman S W, Stein D G, Archer D R and LaPlaca M C 2002 Fibronectin promotes survival and migration of primary neural stem cells transplanted into the traumatically injured mouse brain Cell Transplant. 11 283-95 (Pubitemid 34665829)
158. Kim H, Tator C and Shoichet M 2011 Chitosan implants in the rat spinal cord: biocompatibility and biodegradation J. Biomed. Mater. Res. A 97 395-404
159. Chen W and Abatangelo G 1999 Functions of hyaluronan in wound repair Wound Repair Regen. 7 79-89 (Pubitemid 29200045)
160. Balazs E, Bland P, Denlinger J, Goldman A, Larsen N, Leshchiner E, Leshchiner A and Morales B 1991 Matrix engineering Blood Coagul. Fibrinolysis 2 173-8
161. Hou S, Xu Q, Tian W, Cui F, Cai Q, Ma J and Lee I S 2005 The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin J. Neurosci. Methods 148 60-70 (Pubitemid 41423459)
162. Hogg R E and Chakravarthy U 2006 Visual function and dysfunction in early and late age-related maculopathy Prog. Retinal Eye Res. 25 249-76 (Pubitemid 43782815)
163. Park K I, Teng Y D and Snyder E Y 2002 The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue Nat. Biotechnol. 20 1111-7 (Pubitemid 35285439)
164. Bible E, Chau D, Alexander M, Price J, Shakesheff K and Modo M 2009 Attachment of stem cells to scaffold particles for intra-cerebral transplantation Nat. Protoc. 4 1440-53
165. Mahoney M J and Saltzman W M 2001 Transplantation of brain cells assembled around a programmable synthetic microenvironment Nat. Biotechnol. 19 934-9 (Pubitemid 32947571)
166. Oudega M and Xu X M 2006 Schwann cell transplantation for repair of the adult spinal cord J. Neurotrauma 23 453-67 (Pubitemid 43726321)
167. Karimi-Abdolrezaee S, Eftekharpour E, Wang J, Schut D and Fehlings M G 2010 Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord J. Neurosci. 30 1657-76
168. Saif J et al 2010 Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularization Arterioscler. Thromb. Vasc. Biol. 30 1897-904